All UK intensive care units contribute to ICNARC, generating a rich and comprehensive dataset that captures patient characteristics, interventions, and outcomes. Yet, despite its scope and potential, this resource is often underutilised at the frontline. This session will explore how clinicians and the wider multidisciplinary team (MDT) can make meaningful use of ICNARC data to inform practice, drive quality improvement, and support service development.
Through practical examples and expert insights, we will demystify the reports, highlight common pitfalls in interpretation, and demonstrate how to translate data into actionable change. Attendees will leave with greater confidence in using ICNARC outputs to benchmark performance, identify variation, and ultimately improve patient care.
×
Professor Charlotte Summers
Professor of Intensive Care Medicine, University of Cambridge
Charlotte graduated in both Biomedical Sciences and Medicine from the University of Southampton, and later undertook a PhD at the University of Cambridge investigating the role of inflammation on the pulmonary transit kinetics of human neutrophils, alongside specialist clinical training in Respiratory (East of England) and Intensive Care Medicine (London). She was subsequently appointed as the UK’s first NIHR Clinical Lecturer in Intensive Care Medicine, and went on to be awarded a Fulbright All-disciplines Scholar Award and a Wellcome Trust Fellowship for Postdoctoral Clinician Scientists. Charlotte joined the University of Cambridge School of Clinical Medicine in 2015 from University of California, San Francisco.
:
@charlot_summers
×

Paul Mouncey
Co-Director, ICNARC
Paul is Co-Director, and Clinical Trials Unit Director, at the Intensive Care National Audit & Research Centre (ICNARC) . Paul is an epidemiologist with over 20 years’ experience of conducting multicentre randomised clinical trials, initially in Cancer, but at ICNARC focussed in adult and paediatric critical care. Paul is currently the Joint-Chief Investigator for the UK-ROX trial (NIHR130508), which is a highly challenging trial within the critical care setting, using extensive data collected routinely by the national clinical audit for critical care (Case Mix Programme) database.
Paul is the lead for the Development of an adaptive platform trial in paediatric critical care and sits on the REMAP-CAP International Trial Steering Committee. He sits on both the NIHR Critical Care National Specialty Specialty Group, which has responsibility for overseeing delivery of studies on the NIHR portfolio for critical care, and the UK Critical Care Research Group.
:
@paulmouncey